Skip to content
Screener

Solventum SOLV Other Income (Expense)

Other Income (Expense) at other companies

3M logo
3MMMM
$136M+163%
Sanara MedTech Inc. logo
Sanara MedTech Inc.SMTI
-$2.25M-55.5%
DENTSPLY SIRONA logo
DENTSPLY SIRONAXRAY
$12M+1,300%
Align Technology logo
Align TechnologyALGN
-$9.96M-231%
SANUWAVE Health, Inc. logo
SANUWAVE Health, Inc.SNWV
-$396K+55.4%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$2.8M+16.7%

Other financials

Income statement

See full
Revenue$2.2B+2.2%
Gross profit$1.3B+9.4%
Operating income$181.0M-15.4%
Net income$92.0M+2.2%
EPS (diluted)$0.53+3.9%

Balance sheet

See full
Cash & equivalents$403.0M-18.1%
Total debt$5.8B-25.9%
Total equity$4.8B+31.7%
Total assets$14.2B-5.5%

Cash flow

See full
Operating cash flow$227.0M+34.3%
CapEx$83.0M-24.5%
Free cash flow-$273.0M-241%

Valuation

See full
Market cap$15.15B+20.6%
Enterprise value$20.54B+3.3%
P/E10.6×-22.5×
P/S1.8×+0.3×

Profitability

See full
Gross margin54.7%+0.2pp
Operating margin25%+15.7pp
Net margin17.3%+12.7pp
FCF margin4.6%-13.9pp

Returns & leverage

See full
Return on equity34%+22.3pp
Debt / equity1.2×-0.9×
Current ratio-0.2×

Where this comes from

Reported directly by Solventum in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: Solventum’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:27 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001964738-26-000047
(Millions, except per share data)Three months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Research and development expenses178189367381
Operating income181214262367
Interest expense, net64103125207
Other expense (income), net981319
Income before income taxes108103123141
Provision for (benefit from) income taxes151319(86)
Net income$92$90$105$227
Earnings per share:

Item 1. Financial Statements

FAQ

What is Solventum's other income (expense)?
Solventum (SOLV) reported other income (expense) of -$9M in Q2 2026.
How has Solventum's other income (expense) changed year-over-year?
Solventum's other income (expense) decreased by 12.5% year-over-year, from -$8M to -$9M.
What is the long-term trend for Solventum's other income (expense)?
Over 3 years (2022 to 2025), Solventum's other income (expense) has grown at a 239.1% compound annual growth rate (CAGR), from -$1M to -$39M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about Solventum's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude